Assay Kits_abinScience

Olokizumab (1)

Pogalizumab (1)

Guselkumab (2)

Camidanlumab (1)

Talacotuzumab (1)

Denosumab (3)

Vanucizumab (1)

Edrecolomab (1)

Durvalumab (3)

IL1RL1/ST2 (1)

Tisotumab (1)

Spike glycoprotein E1 (2)

Enoblituzumab (1)

Sacituzumab (1)

RBD (Omicron/BA.4/BA.5) (1)

Ontamalimab (1)

Sirukumab (1)

Tavolimab (1)

Elotuzumab (1)

Daclizumab (1)

Vibecotamab (1)

Cetuximab (3)

Lupartumab (1)

Rolinsatamab (1)

Pacmilimab (1)

cAMP (1)

Imalumab (1)

dsRNA (1)

Mirzotamab (1)

Semorinemab (1)

Semaglutide (1)

Glembatumumab (1)

Balstilimab (1)

Ziltivekimab (1)

Lirilumab (1)

Evolocumab (1)

Ibalizumab (1)

Bimagrumab (1)

Sarilumab (2)

Depatuxizumab (1)

Anifrolumab (1)

Nirsevimab (1)

cGMP (1)

Andecaliximab (1)

ATP7B (1)

Omburtamab (1)

Tilavonemab (1)

B6R/SL-159 (1)

RBD (Omicron/JN.1) (1)

Cetrelimab (1)

Cergutuzumab (1)

Codrituzumab (1)

Alirocumab (1)

Tregalizumab (1)

Daratumumab (3)

Ustekinumab (3)

Losatuxizumab (1)

Icrucumab (1)

Palivizumab (3)

BSA (1)

Farletuzumab (1)

TPP15 (1)

Frovocimab (1)

Nivolumab (5)

Zagotenemab (1)

Befovacimab (1)

RBD (Omicron/KP.2) (1)

Pembrolizumab (3)

Labetuzumab (1)

Astegolimab (1)

RBD (Omicron/BA.5) (3)

Zanolimumab (1)

Ifabotuzumab (1)

Omalizumab (2)

Necitumumab (1)

Ieramilimab (1)

Suptavumab (1)

Protein A (1)

Mirvetuximab (1)

TPP17 (1)

Lodelcizumab (1)

Etanercept (3)

RBD (WT) (1)

Concizumab (1)

CD340/ERBB2 (1)

Sintilimab (1)

Cabiralizumab (1)

Belantamab (1)

dsDNA (1)

Eldelumab (1)

Letolizumab (1)

RBD (6)

Panitumumab (3)

Mavezelimab (1)

Suvizumab (1)

Human β Amyloid (1-42) (1)

Bevacizumab (3)

TPP47 (1)

Tezepelumab (1)

Elezanumab (1)

RBD (Alpha) (1)

Marstacimab (1)

M/Matrix protein (2)

Tislelizumab (1)

Emactuzumab (1)

Teclistamab (1)

Glycoprotein (5)

Lenzilumab (1)

Itolizumab (1)

Spike glycoprotein (9)

Serclutamab (1)

Favezelimab (1)

Foravirumab (1)

Human β Amyloid (1-40) (1)

Brolucizumab (1)

G/Major surface glycoprotein G (1)

Ranibizumab (3)

N/Nucleoprotein (1)

Enfortumab (1)

RBD (Beta) (1)

Obinutuzumab (2)

gG/US4 (2)

Toripalimab (1)

Cixutumumab (1)

Pasotuxizumab (1)

GP/Envelope glycoprotein (4)

Namilumab (1)

Cusatuzumab (1)

Spike Protein (Trimer) (2)

Tesidolumab (1)

Indatuximab (1)

Rafivirumab (1)

TAU pT181 (1)

Varisacumab (1)

Spike glycoprotein (RBD) (1)

Ianalumab (1)

RBD (Gamma) (1)

Afutuzumab (1)

gB/Envelope glycoprotein B (1)

Afasevikumab (1)

Dalotuzumab (1)

Rosopatamab (2)

Tirzepatide (2)

Otilimab (1)

Vorsetuzumab (1)

NP/Nucleocapsid (5)

Tanezumab (1)

Lintuzumab (1)

Tosatoxumab (1)

TAU pT217 (1)

Obiltoxaximab (1)

Benufutamab (1)

Crizanlizumab (1)

EPO/Erythropoietin (1)

Blosozumab (1)

RBD (E484K) (1)

Epcoritamab (1)

gE/Envelope glycoprotein E (1)

Bimekizumab (1)

Figitumumab (1)

Tarextumab (1)

Simlukafusp Alfa (1)

Milatuzumab (1)

Meplazumab (1)

Rituximab (1)

Adalimumab (3)

Oleclumab (1)

Gremubamab (1)

Conatumumab (1)

Inclacumab (1)

Romosozumab (1)

RBD (Kappa) (1)

Glofitamab (1)

gD/Envelope glycoprotein D (1)

Ixekizumab (1)

Ganitumab (1)

Urelumab (1)

IL6 (1)

Disitamab (1)

Alacizumab (1)

Natalizumab (2)

Certolizumab (2)

Zampilimab (1)

Vofatamab (1)

M1R (5)

Drozitumab (1)

Olaratumab (1)

Mirikizumab (2)

RBD (Delta Plus) (1)

Ibritumomab (1)

gC/Envelope glycoprotein C (1)

Remtolumab (1)

Teprotumumab (1)

Utomilumab (1)

Aflibercept (1)

Pertuzumab (3)

Ramucirumab (1)

Romiplostim (2)

Golimumab (2)

Oxelumab (1)

H3L (3)

Lexatumumab (1)

Tovetumab (1)

Dilpacimab (1)

RBD (Delta) (3)

Mosunetuzumab (1)

gC/UL44 (1)

Secukinumab (2)

Apamistamab (1)

Magrolimab (1)

sCD14 (1)

Trastuzumab (2)

Ascrinvacumab (1)

Sotrovimab (1)

Infliximab (2)

Casirivimab (1)

Canakinumab (1)

Dupilumab (3)

E8L (5)

Tigatuzumab (1)

Ipilimumab (2)

Navicixizumab (1)

A29L (6)

Ocaratuzumab (1)

gD/US6 (1)

Tibulizumab (1)

Emibetuzumab (1)

Sibrotuzumab (1)

Zanidatamab (1)

Cinpanemab (1)

Imdevimab (1)

Gevokizumab (1)

Iscalimab (1)

A35R (5)

Faricimab (1)

Tremelimumab (1)

Atezolizumab (3)

SARS-CoV-2 Neutralization Antibody (3)

Carlumab (1)

US8/gE (1)

Vunakizumab (1)

Tocilizumab (3)

Amatuximab (1)

Zenocutuzumab (1)

CD79B (2)

Ivuxolimab (1)

F/Fusion glycoprotein F0 (5)

Basiliximab (1)

Varlilumab (1)

Eculizumab (3)

Nesvacumab (1)

Zalifrelimab (1)

Avelumab (3)

NP/Nucleoprotein (3)

Lorvotuzumab (1)

Spike glycoprotein E2 (2)

Tiragolumab (2)

Lacnotuzumab (1)

Anetumab (1)

Clazakizumab (1)

Recombinant Proteins

Antibodies

Assay Kits

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Quick access

Contact us